Avivagen (VIVXF) Stock Price, News & Analysis

Company Overview

Avivagen Inc. is a Canadian animal-health biotechnology company focused on developing and commercializing non-antibiotic products for livestock and poultry. Its principal technology is OxC-beta™, a feed additive based on oxidized beta-carotene and designed to support immune function, gut health and animal performance.

OxC-beta™ has been marketed as an alternative to in-feed antibiotics and antibiotic growth promoters. The product has been used or evaluated in applications involving poultry, swine and other food-producing animals, with the company targeting producers seeking to improve animal health while reducing reliance on antibiotics.

Avivagen was headquartered in Ottawa, Ontario, and pursued international commercialization through regulatory approvals, distributors and strategic partners in markets outside Canada, including parts of Asia and Latin America. Public information about the company’s current operations and leadership is limited, and its business has historically been centered on the development and commercialization of the OxC-beta™ product line.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/11/2026
• Fiscal Year End: 10/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VIVXF
• CIK: N/A
• Web: www.avivagen.com
• Phone: 613-702-2908
• Fax: N/A
• Employees: 13
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A